Company Market Research Report: ARKRAY, Inc.
Company Overview
- Name: ARKRAY, Inc.
- Mission: Contribute to the health and well-being of people all over the world through the advancement of science and the discovery of new technologies.
- Founded: June 10, 1960
- Founder: Tadashi Doi
- Key People: Yukitoshi Yao, Representative Director
- Headquarters: 701 / 702, Opulence, TPS III 6th Road, Santacruz (East) Mumbai 400 055, India
- Number of Employees: No information is available
- Revenue: No information is available
- Known For: ARKRAY is known for its contributions to medical testing systems such as diabetes testing, urinalysis, and genetic testing. It also supports diagnosis through the development of clinical testing instruments and reagents.
Products
ARKRAY, Inc. offers a diverse range of products in the medical testing field:
1. Diabetes Testing
- Description: Highly accurate analyzers and self-monitoring blood glucose systems for hospital and personal use.
- Key Features: Efficient and accurate diabetes management.
2. Urinalysis / Urine Testing
- Description: Analyzers and reagents for detecting and analyzing urine samples.
- Key Features: Space-saving designs and comprehensive test item management systems.
3. Biochemistry Testing
- Description: Reagents and analyzers for biochemical tests.
- Key Features: Supports on-the-spot testing and high throughput processing.
4. Immunodiagnostic Products
- Description: Offers rapid tests and serology products.
- Key Features: Quick and reliable testing for diseases such as HIV and hepatitis.
5. Point of Care
- Description: Handheld devices for near-patient testing on aspects like blood glucose, haemoglobin, and urinalysis.
- Key Features: Portable, quick results, patient-friendly.
6. Blood Glucose Monitoring (BGM)
- Description: Systems and devices for monitoring blood glucose levels.
- Key Features: Simple, accurate, and efficient for diabetes management at home.
7. Functional Food Materials
- Description: Development of new health-enhancing foods using herbs and fruits.
- Key Features: Anti-glycemic, anti-aging, and anti-metabolic syndrome effects.
Recent Developments
New Locations and Operations
- Dec 01, 2021: Started full-scale operations in six new locations in Europe to expand their global footprint.
Awards and Recognition
- Nov 22, 2022: Awarded the "PRIDE Index 2022 Gold Prize" for LGBTQ measures in the workplace.
- Nov 12, 2021: Received the "PRIDE Index 2021 Gold Rating" for initiatives toward LGBTQ inclusivity.
Product and Manufacturing Expansions
- Jan 29, 2018: Transferred and expanded the Pinghu factory to increase the production of diabetes testing instruments and in-vitro diagnostic reagents.
- Feb 09, 2018: Launched new testing systems for renal functions and lifestyle-related diseases with enhanced data management.
Strategic Growth and Partnerships
- May 28, 2020: Launched a Point of Care Testing Device for diabetes diagnosis in underserved areas globally.
Events and Participations
- Oct 09, 2024: Announced an upcoming webinar on the updated EFLM European Urinalysis guideline.
- Feb 22, 2023: Participated in WORLDLAB - EUROMEDLAB ROMA 2023 event.
Product Innovation
- Global Offerings: Continuously innovates to meet diverse medical needs with high value-added products available in more than 80 countries.
Conclusion
ARKRAY, Inc. is dedicated to advancing healthcare through innovative diagnostic technologies and testing systems. With a focus on global expansion and a commitment to sustainability and diversity, ARKRAY continues to be a leader in the healthcare industry, contributing to improved quality of life and healthcare solutions worldwide.
